Top Banner
1 5 th Inter-Agency Meeting on Coordination and Harmonization of HIV/AIDS, TB and Malaria Strategies Universal Access to HIV/AIDS, TB and Malaria Services in Africa; Challenges and Prospects
33

1 5 th Inter-Agency Meeting on Coordination and Harmonization of HIV/AIDS, TB and Malaria Strategies Universal Access to HIV/AIDS, TB and Malaria Services.

Dec 25, 2015

Download

Documents

Jacob McCormick
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
  • Slide 1
  • 1 5 th Inter-Agency Meeting on Coordination and Harmonization of HIV/AIDS, TB and Malaria Strategies Universal Access to HIV/AIDS, TB and Malaria Services in Africa; Challenges and Prospects
  • Slide 2
  • 2 Overview of Presentation For each of the 3 diseases Situation and Trends Trends in the Response Programmatic Challenges Prospects for the Future For each of the 3 diseases Situation and Trends Trends in the Response Programmatic Challenges Prospects for the Future
  • Slide 3
  • 3 HIV/AIDS Situation -2012 People living with HIV 25 million (71% of global burden) Children 75% decrease in incidence (9) 50%75% decrease in incidence < 50% decrease">
  • 26 Decrease in incidence of malaria cases in AFRO: 2000 2012 On track for >75% decrease in incidence (9) 50%75% decrease in incidence < 50% decrease Insufficient data to make trend conclusions Botswana Cape Verde Eritrea Namibia Rwanda STP South Africa Swaziland Zanzibar Ethiopia Zambia MadagascarAngola, Benin, Burkina Faso, Burundi, Cameroon, CAR, Chad, Comoros, Congo, Cte dIvoire, DRC, Equatorial Guinea, Gabon, Gambia, Ghana, Guinea, Guinea-Bissau, Kenya, Liberia, Malawi, Mali, Mauritania, Mozambique, Niger, Nigeria, Uganda, Sngal, Sierra Leone, South Sudan, Togo, Tanzania (Mainland)* and Zimbabwe 26
  • Slide 27
  • 27 Malaria - Programmatic Challenges Lack of Universal Access to malaria interventions Emerging resistance to pyrethroids and other insecticides Threat of resistance to artemisinin-based medications and other anti-malarials Lack of quality trend data in several countries Moving from accelerated control towards malaria elimination Lack of Universal Access to malaria interventions Emerging resistance to pyrethroids and other insecticides Threat of resistance to artemisinin-based medications and other anti-malarials Lack of quality trend data in several countries Moving from accelerated control towards malaria elimination
  • Slide 28
  • 28 Prospects for the Future HIV/AIDS MDG Target 6A: Have halted by 2015 and begun to reverse the spread of HIV/AIDS. 38.5% reduction in the regional incidence of HIV between 2001 and 2012. 34 countries with decreasing trend, with notable reductions in the incidence MDG Target 6B: Achieve, by 2010, Universal Access to treatment for HIV/AIDS for all those who need it. By the end of 2012, 68% of eligible PLH were receiving ART, an increase of more than 90% since 2009. Most countries in the region have scaled up access to ART, but only 10 countries have attained the target of 80% ART coverage 16 countries with coverage below 50%. More needs to be done to achieve the HIV/AIDS-related MDG Targets
  • Slide 29
  • 29 Prospects for the Future TB Target 6C: Have halted by 2015 and begun to reverse the incidence of malaria and other major diseases. Incidence of tuberculosis decreased in 25 countries while it increased or remained the same in 21 countries On the whole, the MDG target for TB has been achieved for the African Region The gains made need to be sustained and the challenges related to HIV and TB drug resistance addressed
  • Slide 30
  • 30 Prospects for the Future Malaria Target 6C: Have halted by 2015 and begun to reverse the incidence of malaria and other major diseases. The incidence of malaria reduced by 31% between 2000 and 2012 in the African region It is expected to decrease by 39% in the Region by 2015, if the current annual rate of decrease is maintained. 12 countries are on course to meet the MDG target However, the 2015 projected reductions in malaria incidence and mortality are well below the WHA and RBM 2015 targets of reducing malaria incidence rate by 75% and achieving near zero malaria deaths. More needs to be done to achieve the Malaria-related MDG Target
  • Slide 31
  • 31 Prospects for the Future HIV, TB & Malaria Countries to make smart investments for enhanced impact on disease burden More effectively target interventions to hotspots or areas or populations with the greatest needs Focus on areas where progress has been limited Make use of new opportunities Increase investment in health systems Improve the monitoring of progress made and the use of data for decision-making Countries to plan for the post-2015 era to improve Universal Health Coverage
  • Slide 32
  • 32 Prospects for the Future HIV, TB & Malaria Partners to Focus on areas of comparative advantage to enhance coordinated support to countries Development partners to focus on strategic and catalytic upstream actions Implementing partners to focus on operational level actions Improve collaboration among ourselves
  • Slide 33
  • 33